基于疾病经济负担视角开展肿瘤心脏病学的探索  

Exploration of Cardio-Oncology from the Perspective of Economic Burden of Disease

作　　者：张敏[1] 林瑾仪[1,2] 马元吉 程蕾蕾 ZHANG Min;LIN Jinyi;MA Yuanji(Zhongshan Hospital,Fudan University,Shanghai,200032,China;不详)

机构地区：[1]复旦大学附属中山医院,上海200032 [2]上海市心血管病研究所,上海200032 [3]复旦大学附属中山医院心脏超声诊断科,上海200031

出　　处：《中国卫生质量管理》2020年第3期19-22,共4页Chinese Health Quality Management

基　　金：国家自然科学基金面上项目(81771840);上海市卫生系统优秀人才培养计划(2017BR027).

摘　　要：目的探讨肿瘤心脏病学科的发展现状与前景。方法基于二手数据,分析恶性肿瘤和心血管疾病的疾病风险及疾病经济负担,梳理国内外肿瘤心脏病学的发展现状。结果恶性肿瘤与心血管疾病是全球负担最大的两种疾病。若同时罹患这两种疾病将大大加剧家庭、社会和国家的经济负担。结论从疾病经济负担视角出发,应努力发展肿瘤心脏病学,深入进行随机对照的大样本、多中心、前瞻性的肿瘤心脏病学疾病经济负担研究。Objective To explore the current situation and prospect of the development of cardio-oncology.Methods Based on secondary data,the disease risk and economic burden of malignant tumor and cardiovascular disease were analyzed,and the development status of cardio-oncology at home and abroad were sorted out.Results Malignant tumor and cardiovascular disease were the two most burdensome diseases in the world.The economic burden on the family,society and country is greatly increased if the patient suffers from malignant tumor and cardiovascular disease at the same time.Conclusion From the perspective of economic burden of disease,efforts should be made to develop cardio-oncology,and to conduct in-depth study on disease economic burden of cardio-oncology with large sample,multi-center and prospective randomized controlled study design.

关 键 词：肿瘤心脏病学 恶性肿瘤 心血管疾病 疾病经济负担 

分 类 号：R197.3[医药卫生—卫生事业管理] R732[医药卫生—公共卫生与预防医学]